Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS



Investor Research for Marijuana Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing


Featured marijuana stocks

Profile Solutions, Inc.

(OTC: PSIQ)

Profile Solutions, Inc. (OTC: PSIQ) A Security Technology developer, system designer and integrator, specializing in servicing Fortune 100 Customers, Law Enforcement and Government Agencies/Facilities, Medical and Recreational cannabis industry-related businesses.

Interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

Marijuana News

#Marijuana Stock News: Organigram (TSX VENTURE: $OGI) (OTCQB: $OGRMF) Makes Key Hire to Advance Oils and Extracts Division
MONCTON, NEW BRUNSWICK - January 13, 2017 (Investorideas.com Newswire) Licensed medical marijuana producer Organigram Holdings Inc. ("Organigram" or the "Company") (TSX VENTURE:OGI)(OTCQB:OGRMF) is pleased to announce the addition of Michel Robichaud to its Senior Management Team.

#Cannabis #Stock News: Valens GroWorks (CSE: $VGW) Licensing Inspection Completed
VANCOUVER, BRITISH COLUMBIA - January 13, 2017 (Investorideas.com Newswire) Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN)(the "Company") is pleased to announce the completion, by the Regional Inspectorate of the Office of Controlled Substances of Health Canada

#Cannabis Stock News: Canabo Medical Inc. (TSX VENTURE: $CMM) Announces 2 New Clinic Openings
VANCOUVER, BC - January 12, 2017 (Investorideas.com Newswire) Canabo Medical Inc. (TSX VENTURE: CMM) ("Canabo" or the "Company") is pleased to announce it has opened new clinics in the Moncton, New Brunswick area and Kingston, Ontario.

#Cannabis #Stock News: Mettrum Health Corp. (TSX VENTURE:$MT) to Acquire Bodystream Cannabis Clinic Network
TORONTO, ONTARIO - January 11, 2017 (Investorideas.com Newswire) Mettrum Health Corp. ("Mettrum" or the "Corporation") (TSX VENTURE:MT), a fully integrated medical cannabis producer under the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has acquired all of the outstanding shares of 2344823 Ontario Inc., d/b/a Bodystream ("Bodystream"), a leading network of medical cannabis clinics with 14 current locations across Ontario

Bay Street #Cannabis - Canada's First Equity #Crowdfunding Portal Dedicated to the Cannabis Sector (BayStreetCannabis.ca)
VANCOUVER, BC - January 10, 2017 (Investorideas.com Newswire) NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES - Two of our country's newest and most exciting sectors, cannabis and crowdfunding, are meeting at the centre of commerce in Canada with the launch of "Bay Street Cannabis."

#Viridian Cannabis Deal Tracker for Week Ended 1/6/2017
January 10, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian CANNABIS DEAL TRACKER for the week ending January 6th.

#Cannabis Stock News: CannaRoyalty (CSE: $CRZ) to Acquire 20% of Anandia Labs, a Leader in Cannabis Testing, Extraction and Genetics
OTTAWA, ONTARIO - January 9, 2017 (Investorideas.com Newswire) CannaRoyalty Corp. (CSE:CRZ)(CSE:CRZ.CN) is pleased to announce the signing of a letter of intent ("LOI") to acquire a 20% equity interest in Anandia Laboratories Inc. Anandia Labs is a cannabis biotechnology company with a focus on providing leading analytical testing services and developing cannabis strains for safe and effective medical application

North American #Marijuana Sales to Top $20.2 Billion by 2021, Grew 30 Percent in 2016
OAKLAND, Calif. - January 6, 2017 (Investorideas.com Newswire) Arcview Market Research, the leading publisher of cannabis market research, released a new 2016 North American cannabis market size estimate as well as projections for the market through 2021

#Cannabis #Stock News: Emblem Corp. (TSX VENTURE: $EMC) Announces $10 Million Special Warrant Bought Deal Financing
TORONTO, ONTARIO - January 6, 2017 (Investorideas.com Newswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Emblem Corp. (the "Company") (TSX VENTURE:EMC) announces that is has entered into an engagement letter with PI Financial Corp., on behalf of a syndicate of underwriters, (collectively, the "Underwriters") pursuant to which the Underwriters have agreed to purchase 2,754,821 special warrants of the Company (the "Special Warrants") on an underwritten basis at a price per Special Warrant of $3.63 for aggregate gross proceeds of $10 million

#Cannabis #Stock News: Corazon (TSX VENTURE: $CGW) Signs LOI to Acquire 100% of NanoSphere Health Sciences and Innovative #Cannabinoid Delivery System
VANCOUVER, BRITISH COLUMBIA - January 5, 2017 (Investorideas.com Newswire) Corazon Gold Corp. (TSX VENTURE:CGW) ("Corazon" or the "Company") is pleased to announce that it has signed a Letter of Intent dated December 22, 2016, with NanoSphere Health Sciences LLC ("NanoSphere") to acquire 100% of the issued and outstanding shares of NanoSphere.

Subscribe to Marijuana News RSS

Submit Articles   Search More Articles

Cannabis Law News | Cannabis Law Report

Stock Quotes

Expert Corner Michael J. Swartz, Analyst Viridian Capital & Research, LLC

Michael Swartz

Mr. Swartz serves as Senior Analyst at Viridian Capital & Research, where he leads all modeling and valuation work for the firm’s M&A and fund raising assignments. He served as co-portfolio manager for the Osprey Financial Group, where he analyzed publicly traded companies with market capitalizations from $50 million to $1 billion and prepared buy-side equity reports containing buy-recommendations and original valuations derived from fundamental & technical analysis. In addition, Mr. Swartz served as the fund’s Asian Economist, analyzing economic and geopolitical factors and assessing the Asia-Pacific region for attractive investment opportunities. Previously, Mr. Swartz worked as an Analyst at TBG Holdings, assisting clients with researching strategic options as it relates to market opportunities, competitive positioning, and allocation of resources. Mr. Swartz holds a B.B.A. in Finance and minor in Criminal Justice from the University of North Florida.

CANNABIS STOCKS: 2014 REVIEW AND 2015 OUTLOOK

Viridian Cannabis Index Gains 38.4% for 2014
Cannabis Stocks Will Attract More Institutional Funding in ’15 and M&A Activity Will Rise
More Companies Will Fail as Shake Out Continues

More institutional capital will flow into public cannabis companies in 2015, reflecting the sector’s growth prospects, but some individual companies will falter as investors and regulators demand performance. The backdrop and general momentum of the cannabis sector is positive as the reality of its national growth potential becomes more and more apparent, but the shake out of individual players that began last year will continue in 2015, as hype will not be enough to sustain companies in the eyes of investors, and may contribute to action by regulators. We will likely see a number of public cannabis companies fail this year. With increasing flows of ‘smart money’ will come increasing demand for companies to demonstrate top-tier management and sustainable business models.

Report in pdf

Sign Up

Sign Up for Investing Ideas & Stock Alerts

Email:

www.Investorideas.com

Marijuana / Hemp Stock Directory Preview

22 nd Century Group Inc. ( NYSE MKT:XXII ) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company.

ABATTIS BIOCEUTICALS ( OTC:ATTBF ) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Advanced Cannabis Solutions, Inc. ( OTC:CANN ) provides services to the regulated cannabis industry throughout the United States. We will lease growing space and related facilities (commercial real estate and equipment) to licensed marijuana business operators for their production needs. We are pursuing ancillary business products and services including customized finance, capital formation, banking, regulatory compliance consulting and advanced logistical support for grow operations. ACS does not grow, harvest, distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

AFFINOR GROWERS ( CNSX:AFI ; OTC:RSSFF ) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

Agritek Holdings Inc ( OTC:AGTK ) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc. Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

American Green Inc  ( OTC:ERBB ) Founded back in 2009 as one of the first publicly-traded medical marijuana-related companies in the world, American Green is proud to have the largest certified shareholder base which now numbers well over 50,000. The Company is keenly focused on developing, retailing, branding, and establishing commercial cultivation solutions under its proprietary American Green name along with our partners who are licensed retail medical marijuana dispensaries. American Green believes that the renewal of the legalized cannabis industry in the United States will aid in getting our economy back on its feet through increased employment in all related sectors -- retail, real estate, contracting, farming and more. Additional revenues, fueled by taxing cannabis sales, and the decreased cost of housing prisoners who are no longer in prison for possession of cannabis should contribute to the renewal. Hard work and a clear vision propel American Green into the future. The centerpiece of our company is ZaZZZ, our unique automated vending solution designed specifically around American Green's licensed proprietary patent technology.

Aphria Inc ( TSX: APH.V) a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria.

Bedrocan Cannabis Corp ( TSX:BED.V ) is the global leader in medicinal cannabis research and product innovation and has been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan’s strains of pharmaceutical-grade cannabis are used by patients in seven countries, including Canada. The company is committed to clinical research, with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada.

BREEDIT CORP ( OTC:BRDT ) through its Israeli subsidiary, BreedIT Ltd  http://www.ibreedit.com , is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT's proven iBreedIT® - the Intelligent Decision Support System (IDSS) for breeders which was developed by a team consisting of among the world's leading breeding specialists for optimizing the breeding processes, services the plant breeding needs of corporations, research and government institutions. BreedIT's IDSS provides advanced solutions for generating and disseminating knowledge aimed at assisting breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively. Founded in 2013, BreedIT Corp has offices in New York, New York and in Rehovot, Israel.

Bud Genius, Inc ( OTC:RIGH ) An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories.

See the full stock directory here